The role of HER 2 is to provide the cells with normal signals for growth and division. However, in some cancers, the HER 2 gene is abnormal, leading to the overexpression of the HER 2 protein, which makes the cancer cells lose their normal growth and division control, and then triggers the occurrence and development of cancer. HER 2 is also an important target target, and through specific targeted therapy targeting HER 2 overexpression, it can effectively inhibit the growth and spread of cancer cells and achieve the therapeutic effect of treating cancer. After binding to ligands such as growth factors on the cell surface, HER 2 promotes cell growth and differentiation by activating downstream signaling pathways.

At present, various drugs targeting ERBB2/HER2/CD340 are constantly under development, and taking drugs alone or together with other products to treat diseases has become a new method and remarkable achievements have been made. ERBB2/HER2/CD340 protein has shown important research value and application prospects in tumor biology, and drug research and development. With further research and technological advances, ERBB2/HER2/CD340 protein products are also essential. Alpha Lifetech can provide ERBB2/HER2/CD340 corresponding products and help each customer's research and development. Alpha Lifetech focuses on high-precision detection development and validation services to support drug screening and biosimilar discovery. Our detection methods, including ELISA, cell-based functional testing, and flow cytometry, have undergone rigorous sensitivity, specificity, and reproducibility testing. In addition to testing and development, our team also provides data analysis, scheme optimization, and cross-species reactivity testing to ensure reliable results.